recombinant chaperonin 10

From Aaushi
Jump to navigation Jump to search

Indications

* may be used in combination with glucocorticoids &/or disease-modifying antirheumatic drugs (DMARDs)

Dosage

5-10 mg IV twice weekly for 12 weeks

Mechanism of action

More general terms

References

  1. Vangus D et al, Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: A double-blind randomised trial. Lancet 2006, 368:855 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16950363